Press Releases
July 17, 2025
CFO of Egetis Therapeutics acquires shares
Regulatory
July 15, 2025
Egetis receives FDA Breakthrough Therapy Designation for tiratricol for MCT8 deficiency
June 16, 2025
Egetis announces exclusive distribution agreement with Er-Kim for Emcitate® in Türkiye
Upcoming event
August 21, 2025
Latest presentation
April 30, 2025
Latest Report
April 30, 2025
Calendar and upcoming reports
August 21, 2025
Interim Report Q2 2025 (7:00am CEST)
November 7, 2025
Interim Report Q3 2025 (7:00am CET)